Comparison of Two Analytical Platforms for CSF Biomarkers of Alzheimer’s Disease

Table 2

CSF biomarker concentrations.

Proteins	INNOTEST		INNOBIA
	AD patients	Control subjects	AD patients	Control subjects
A𝛽1--42	645.5±282.83	1659.6±660.17	297.7±99.8	510.88±125.75
T-tau	572.73±438.61	167.23±46.5	122.0±86.64	40.76±15.75
P-tau181p	86.71±33.57	41.03±10.45	61.0±23.11	25.0±4.44